Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NR1H2 | P55055 | 3/20 | 0.34 |
| ▸ | NR1H3 | Q13133 | 3/20 | 0.34 |
| ▸ | CHKA | P35790 | 3/20 | 0.32 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.32 |
| ▸ | CA12 | O43570 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | CA2 | P00918 | 1/20 | 0.32 |
| ▸ | LMNA | P02545 | 1/20 | 0.32 |
| ▸ | CA5A | P35218 | 1/20 | 0.32 |
| ▸ | CA9 | Q16790 | 1/20 | 0.32 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.32 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.32 |
| ▸ | CA5B | Q9Y2D0 | 1/20 | 0.32 |
| ▸ | ACHE | P22303 | 1/20 | 0.32 |
| ▸ | CASP1 | P29466 | 1/20 | 0.32 |
| ▸ | RECQL | P46063 | 1/20 | 0.32 |
| ▸ | TSHR | P16473 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25365911 | 1.00 | NR1H2 (0.34) | NR1H2NR1H3CHKACYP3A4CA12 | |
| Ammonia Solution, Strong SCHEMBL2457320 | 0.96 | — | — | |
| Dimethylamine SCHEMBL29203962 | 0.87 | ACHE (0.32) | NR1H2NR1H3ACHE | |
| SCHEMBL14811593 | 0.86 | — | — | |
| SCHEMBL27603876 | 0.85 | CCNB2 (0.31) | NR1H2NR1H3ALDH1A1 | |
| Ammonia Solution, Strong SCHEMBL6823706 | 0.83 | TSHR (0.32) | TSHR | |
| SCHEMBL31557611 | 0.83 | TSHR (0.38) | TSHR | |
| SCHEMBL31557612 | 0.83 | TSHR (0.38) | TSHR | |
| SCHEMBL24524284 | 0.83 | CYP3A4 (0.41) | CYP3A4CA12ALDH1A1CA2LMNA | |
| SCHEMBL27608982 | 0.79 | NR1H2 (0.35) | NR1H2NR1H3CHKA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 30 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| JP-6080894-A | — | — | None | — | — | JP | disclosed |
| JP-60051132-A | — | — | None | — | — | JP | disclosed |
| US-12540073-B2 | Heterogeneous hydrogen-catalyst solid fuel reaction mixture and reactor | BRILLIANT LIGHT POWER, INC. (US) | 2026-02-03 | — | — | US | disclosed |
| US-12441823-B2 | Resin composition for optical shaping | KURARAY NORITAKE DENTAL INC. (JP) | 2025-10-14 | — | — | US | disclosed |
| US-12030970-B2 | Curable composition and stereolithographic resin composition comprising same | KURARAY CO., LTD. (JP) | 2024-07-09 | — | — | US | disclosed |
| EP-3900693-B1 | USE OF A RESIN COMPOSITION | KURARAY NORITAKE DENTAL INC (JP) | 2024-03-20 | — | — | EP | disclosed |
| US-11814454-B2 | Curable composition, and resin composition for stereolithography prepared therefrom | KURARAY CO., LTD. (JP) | 2023-11-14 | — | — | US | disclosed |
| US-20230045778-A9 | HETEROGENEOUS HYDROGEN-CATALYST SOLID FUEL REACTION MIXTURE AND REACTOR | BRILLIANT LIGHT POWER, INC. (US) | 2023-02-09 | — | — | US | disclosed |
| US-20220325025-A1 | CURABLE COMPOSITION AND STEREOLITHOGRAPHIC RESIN COMPOSITION COMPRISING SAME | KURARAY CO., LTD. (JP) | 2022-10-13 | — | — | US | disclosed |
| US-20220242978-A1 | CURABLE COMPOSITION, AND RESIN COMPOSITION FOR STEREOLITHOGRAPHY PREPARED THEREFROM | KURARAY CO., LTD. (JP) | 2022-08-04 | — | — | US | disclosed |
| US-8546578-B2 | Iodonium Cyclophanes for SECURE arene functionalization | NUTECH VENTURES (US) | 2013-10-01 | — | — | US | disclosed |
| US-20110190505-A1 | Iodonium Cyclophanes for SECURE Arene Functionalization | NATIONAL SCIENCE FOUNDATION | 2011-08-04 | — | — | US | disclosed |
| US-20110114075-A1 | HETEROGENEOUS HYDROGEN-CATALYST REACTOR | BRILLIANT LIGHT POWER, INC. | 2011-05-19 | — | — | US | disclosed |
| EP-2318307-A2 | HETEROGENEOUS HYDROGEN-CATALYST REACTOR | Blacklight Power, Inc. (US) | 2011-05-11 | — | — | EP | disclosed |
| WO-2010014684-A2 | HETEROGENEOUS HYDROGEN-CATALYST REACTOR | BLACKLIGHT POWER, INC. (US) | 2010-02-04 | — | — | WO | disclosed |
| EP-0799713-B1 | Thermal transfer donor element comprising a colourless sublimable compound and image forming process | MINNESOTA MINING & MFG (US) | 2000-07-19 | — | — | EP | disclosed |
| EP-0799713-A1 | Thermal transfer donor element comprising a colourless sublimable compound and image forming process | MINNESOTA MINING AND MANUFACTURING COMPANY (US) | 1997-10-08 | — | — | EP | disclosed |
| JP-H0680894-A | AZO-BASED COMPOUND | MITA IND CO LTD | 1994-03-22 | — | — | JP | disclosed |
| JP-S6051132-A | SEPARATION OF CIS- AND TRANS-ISOMERS OF 1,3- OR 1,4-DIMETHYLCYCLOHEXANE | TEIJIN LTD | 1985-03-22 | — | — | JP | disclosed |
| US-4153630-A | Inclusion compounds, process for preparation thereof, and process for separating isomers using the inclusion compounds | TEIJIN LIMITED (JP) | 1979-05-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11814454-B2 | Curable composition, and resin composition for stereolithography prepared therefrom | WASF2, COPE, ARCN1 | NR1H2 3669/4885NR1H3 3617/4885CHKA 2795/4885 |
| US-20220242978-A1 | CURABLE COMPOSITION, AND RESIN COMPOSITION FOR STEREOLITHOGRAPHY PREPARED THEREFROM | WASF2, COPE, ARCN1 | NR1H2 3669/4885NR1H3 3617/4885CHKA 2795/4885 |
| US-12030970-B2 | Curable composition and stereolithographic resin composition comprising same | ARL1, ASH2L, VCL | NR1H2 3504/4885NR1H3 3419/4885CHKA 1076/4885 |
| US-20110190505-A1 | Iodonium Cyclophanes for SECURE Arene Functionalization | ABL1, SLC7A5, DDC | NR1H2 4775/4885NR1H3 4569/4885CHKA 2904/4885 |
| US-20220325025-A1 | CURABLE COMPOSITION AND STEREOLITHOGRAPHIC RESIN COMPOSITION COMPRISING SAME | ARL1, VCL, ARCN1 | NR1H2 3902/4885NR1H3 3889/4885CHKA 1302/4885 |
| US-12540073-B2 | Heterogeneous hydrogen-catalyst solid fuel reaction mixture and reactor | SCO2, SOD1, HAO2 | NR1H2 1467/4885NR1H3 2089/4885CHKA 2587/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.